OPTN OptiNose Inc

Price (delayed)

$1.06

Market cap

$119.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.27

Enterprise value

$198.83M

Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S. ...

Highlights
OPTN's EPS has soared by 63% YoY and by 16% from the previous quarter
OptiNose's net income has soared by 55% YoY and by 13% from the previous quarter
The equity has declined by 34% year-on-year and by 15% since the previous quarter

Key stats

What are the main financial stats of OPTN
Market
Shares outstanding
113.04M
Market cap
$119.82M
Enterprise value
$198.83M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.69
Earnings
Revenue
$74.02M
EBIT
-$10.93M
EBITDA
-$10.52M
Free cash flow
-$32.43M
Per share
EPS
-$0.27
Free cash flow per share
-$0.29
Book value per share
-$0.88
Revenue per share
$0.66
TBVPS
$0.74
Balance sheet
Total assets
$83.71M
Total liabilities
$182.92M
Debt
$130.65M
Equity
-$99.22M
Working capital
$48.42M
Liquidity
Debt to equity
-1.32
Current ratio
2.48
Quick ratio
2.01
Net debt/EBITDA
-7.51
Margins
EBITDA margin
-14.2%
Gross margin
89%
Net margin
-41.5%
Operating margin
-22.2%
Efficiency
Return on assets
-30.8%
Return on equity
N/A
Return on invested capital
-37%
Return on capital employed
-21.4%
Return on sales
-14.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPTN stock price

How has the OptiNose stock price performed over time
Intraday
3.92%
1 week
-1.85%
1 month
2.91%
1 year
-1.85%
YTD
-17.83%
QTD
1.92%

Financial performance

How have OptiNose's revenue and profit performed over time
Revenue
$74.02M
Gross profit
$65.86M
Operating income
-$16.45M
Net income
-$30.76M
Gross margin
89%
Net margin
-41.5%
The operating margin has surged by 67% year-on-year and by 31% since the previous quarter
The operating income has surged by 66% year-on-year and by 28% since the previous quarter
OptiNose's net income has soared by 55% YoY and by 13% from the previous quarter
OPTN's net margin has soared by 55% YoY and by 17% QoQ

Growth

What is OptiNose's growth rate over time

Valuation

What is OptiNose stock price valuation
P/E
N/A
P/B
N/A
P/S
1.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.69
OPTN's EPS has soared by 63% YoY and by 16% from the previous quarter
The equity has declined by 34% year-on-year and by 15% since the previous quarter
OPTN's price to sales (P/S) is 62% less than its 5-year quarterly average of 4.1 and 23% less than its last 4 quarters average of 2.0
OptiNose's revenue has increased by 4.3% QoQ

Efficiency

How efficient is OptiNose business performance
The company's return on invested capital has surged by 81% YoY
OPTN's ROS has soared by 79% YoY and by 34% from the previous quarter
The ROA has grown by 45% YoY and by 7% from the previous quarter

Dividends

What is OPTN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPTN.

Financial health

How did OptiNose financials performed over time
OptiNose's total assets is 54% less than its total liabilities
OptiNose's total assets has decreased by 27% YoY and by 22% from the previous quarter
The total liabilities has declined by 6% since the previous quarter and by 3.1% year-on-year
The equity has declined by 34% year-on-year and by 15% since the previous quarter
OptiNose's debt to equity has increased by 25% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.